Schuyler Kevin 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Schuyler Kevin
Director
Transactions
- Purchase
Common Stock
2023-09-29$2.74/sh+700$1,918→ 700 total
Holdings
- 5,768(indirect: By LLC)
Common Stock
- 121(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.72 through $2.78, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Mr. Schuyler has control over MVA 151 Investors, LLC.